Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tezepelumab
tezepelumab
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
chronic hives
chronic urticaria
clinical trials
Sanofi
Regeneron
dupilumab
Amgen
tezepelumab
Allakos
lirentelimab
Celldex Therapeutics
barzolvolimab
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
Amgen builds case for severe asthma drug tezepelumab
Pharmaforum
Mon, 09/6/21 - 09:11 pm
Amgen
AstraZeneca
tezepelumab
asthma
nasal polyps
AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA
Endpoints
Thu, 07/29/21 - 11:10 am
AstraZeneca
Amgen
tezepelumab
asthma
Dupixent
Sanofi
Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent
Fierce Biotech
Thu, 05/13/21 - 10:57 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
Sanofi
Dupixent
FDA
Amgen asks FDA for approval of key asthma drug
BioPharma Dive
Mon, 05/10/21 - 08:15 pm
Amgen
FDA
asthma
tezepelumab
Amgen-AstraZeneca Experimental Asthma Drug Surprisingly Flops in Phase III
BioSpace
Tue, 12/22/20 - 10:47 am
Amgen
AstraZeneca
asthma
clinical trials
tezepelumab
Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3
Fierce Pharma
Tue, 11/10/20 - 10:41 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
clinical trials
Amgen and Astra hope to carve out a place in asthma
EP Vantage
Wed, 09/2/20 - 07:48 pm
clinical trials
AstraZeneca
Amgene
asthma
tezepelumab
AstraZeneca, Amgen whip up some blockbuster excitement with a possible game-changing asthma drug
Endpoints
Thu, 09/7/17 - 09:33 am
AstraZeneca
Amgen
tezepelumab
asthma